Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon

ABSTRACT The ABC transporters Candida glabrata Cdr1 (CgCdr1), CgPdh1, and CgSnq2 are known to mediate azole resistance in the pathogenic fungus C. glabrata. Activating mutations in CgPDR1, a zinc cluster transcription factor, result in constitutive upregulation of these ABC transporter genes but to various degrees. We examined the genomewide gene expression profiles of two matched azole-susceptible and -resistant C. glabrata clinical isolate pairs. Of the differentially expressed genes identified in the gene expression profiles for these two matched pairs, there were 28 genes commonly upregulated with CgCDR1 in both isolate sets including YOR1, LCB5, RTA1, POG1, HFD1, and several members of the FLO gene family of flocculation genes. We then sequenced CgPDR1 from each susceptible and resistant isolate and found two novel activating mutations that conferred increased resistance when they were expressed in a common background strain in which CgPDR1 had been disrupted. Microarray analysis comparing these reengineered strains to their respective parent strains identified a set of commonly differentially expressed genes, including CgCDR1, YOR1, and YIM1, as well as genes uniquely regulated by specific mutations. Our results demonstrate that while CgPdr1 activates a broad repertoire of genes, specific activating mutations result in the activation of discrete subsets of this repertoire.

[1]  K. Struhl,et al.  A nuclear receptor-like pathway regulating multidrug resistance in fungi , 2008, Nature.

[2]  R. Homayouni,et al.  Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.

[3]  M. Voet,et al.  Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.

[4]  G. Fink,et al.  A Saccharomyces gene family involved in invasive growth, cell-cell adhesion, and mating. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. C. Bell,et al.  Candida albicans PLD I activity is required for full virulence. , 2004, Medical mycology.

[6]  K. Barker,et al.  An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicans , 2009, Antimicrobial Agents and Chemotherapy.

[7]  Eun-Jung Cho,et al.  Global protein expression profiling of budding yeast in response to DNA damage , 2007, Yeast.

[8]  T. Myers,et al.  Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates , 2010, Antimicrobial Agents and Chemotherapy.

[9]  G. Owsianik,et al.  Control of 26S proteasome expression by transcription factors regulating multidrug resistance in Saccharomyces cerevisiae , 2002, Molecular microbiology.

[10]  K. Marr,et al.  Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis , 2004, Antimicrobial Agents and Chemotherapy.

[11]  G. Fadda,et al.  Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence , 2009, PLoS pathogens.

[12]  J. Bennett,et al.  Function of Candida glabrata ABC transporter gene, PDH1 , 2003, Yeast.

[13]  T. Hallstrom,et al.  Multiple Pdr1p/Pdr3p Binding Sites Are Essential for Normal Expression of the ATP Binding Cassette Transporter Protein-encoding Gene PDR5* , 1996, The Journal of Biological Chemistry.

[14]  J. Lopez-Ribot,et al.  Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation , 2003, Journal of Clinical Microbiology.

[15]  Gaëlle Lelandais,et al.  The Central Role of PDR1 in the Foundation of Yeast Drug Resistance* , 2007, Journal of Biological Chemistry.

[16]  T. A. Brown,et al.  A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. , 1990, Nucleic acids research.

[17]  M. Choti,et al.  Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy , 2006, Journal of Clinical Microbiology.

[18]  Mason Zhang,et al.  Functional and Structural Diversity in the Als Protein Family of Candida albicans* , 2004, Journal of Biological Chemistry.

[19]  Ronald W. Davis,et al.  Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Yuan-Ying Jiang,et al.  RTA2, a novel gene involved in azole resistance in Candida albicans. , 2008, Biochemical and biophysical research communications.

[21]  D. Ward,et al.  Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata , 1998, Antimicrobial Agents and Chemotherapy.

[22]  G. Reboux,et al.  Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype , 1994, Journal of clinical microbiology.

[23]  C. van Broeckhoven,et al.  Molecular biological characterization of an azole-resistant Candida glabrata isolate , 1997, Antimicrobial agents and chemotherapy.

[24]  G. Fadda,et al.  The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata , 2008, Molecular microbiology.

[25]  S. Falkow,et al.  An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. , 1999, Science.

[26]  R. Homayouni,et al.  A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate , 2008, Eukaryotic Cell.

[27]  D. Sanglard,et al.  The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents , 1999, Antimicrobial Agents and Chemotherapy.

[28]  J. Bennett,et al.  Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants , 2006, Antimicrobial Agents and Chemotherapy.

[29]  M. Ghannoum,et al.  Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. , 2001, Microbiology.

[30]  B. Spellberg,et al.  Nosocomial fungal infections: epidemiology, diagnosis, and treatment. , 2007, Medical mycology.

[31]  T. Patterson,et al.  Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection , 2008, Antimicrobial Agents and Chemotherapy.

[32]  R. Kolter,et al.  The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. , 2004, Gene.

[33]  T. Edlind,et al.  Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor , 2004, Antimicrobial Agents and Chemotherapy.

[34]  A. Tinkelenberg,et al.  Transcriptional Profiling Identifies Two Members of the ATP-binding Cassette Transporter Superfamily Required for Sterol Uptake in Yeast* , 2002, The Journal of Biological Chemistry.